BioCentury
ARTICLE | Clinical News

Alliance to continue Oxygent development

March 13, 2001 8:00 AM UTC

ALLP and partner Baxter (BAX) plan to continue development of ALLP's Oxygent perflubron blood substitute based on preliminary analysis of Phase III safety data that showed no evidence linking the prod...